Topic: COVID-19 pandemic

Opinion Leader: Federal government must provide predictable funding for health research

The federal government needs to make it an urgent priority to provide increased and predictable funding for health and biosciences research, or risk losing the nation’s health research workforce to competing countries like the U.S., the U.K. and Australia, says Paul-Émile Cloutier, president and CEO of HealthCareCAN, in an op-ed.

How Canada can upskill its workforce after the COVID-19 pandemic

The disruption caused by the COVID-19 pandemic has created the perfect conditions to consider new, innovative approaches to rapidly upskill and redeploy domestic talent, say AJ Tibando and Arvind Gupta, the executive director and the CEO of Palette Skills, respectively, in an opinion piece.

To shift to a circular economy, we need to harness local expertise on plastics

Building a circular economy for plastics in Canada will take smart solutions, says Christina Seidel, executive director of the Recycling Council of Alberta and co-chair of the Plastics Alliance of Alberta, in an op-ed. These include locally driven initiatives, collaboration across sectors and organizations, research investment and innovation to eliminate unnecessary plastics and reduce plastic waste.

Calgary vaccine developer reaches deal with Manitoba government after hearing no response from Ottawa

Providence Therapeutics, a Calgary biotechnology company in human trials with its COVID-19 vaccine, struck a supply deal with the Government of Manitoba after sending the federal government a proposal and receiving no response. In a video, Providence founder and CEO Brad Sorenson criticized Ottawa’s “apathetic response” as “unacceptable” and he implored the government to take initiative to establish a secure domestic vaccine supply.

Biotechnology and engineering biology roadmap plus investment are key to Canada’s economic recovery

The federal government needs to support an inclusive engineering biology ecosystem that leverages Canadian-grown capacities across industry, academia and government, Bettina Hamelin, president and CEO of Ontario Genomics, says in an editorial. Canada needs a comprehensive and aligned roadmap for a public-private partnership and investment strategy to benefit from the increasing opportunities in this emerging sector, she says.